Corcept Therapeutics Incorporated

CORT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$19$35$21$30
Dep. & Amort.$0$0$0$0
Deferred Tax$9-$18-$14-$4
Stock-Based Comp.$0$19$22$17
Change in WC$3$8-$22$17
Other Non-Cash$22-$1-$2-$2
Operating Cash Flow$54$44$5$59
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$37-$23-$115-$145
Inv. Sales/Matur.$52$93$112$80
Other Inv. Act.$0$0$0$0
Investing Cash Flow$15$70-$3-$64
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$4$13$0$0
Stock Repurch.-$42-$103$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$8-$12-$40-$5
Financing Cash Flow-$46-$103-$40-$5
Forex Effect-$0$2$0$0
Net Chg. in Cash$22$13-$38-$10
Supplemental Information
Beg. Cash$103$90$128$137
End Cash$125$103$90$128
Free Cash Flow$54$44$5$59
Corcept Therapeutics Incorporated (CORT) Financial Statements & Key Stats | AlphaPilot